Restore Medical Enters International Markets With Pillar Procedure For Obstructive Sleep Apnea; Implantable First-Line Treatment For Sleep Apnea And Snoring Now Available In Asia

ST. PAUL, Minn.--(BUSINESS WIRE)--March 9, 2005--Restore Medical, a leading provider of medical technologies to address sleep-disordered breathing, today announced that its Pillar(R) Procedure is now available internationally. As part of its global expansion, Restore Medical is pleased to announce signed partnerships with Bedtime Medical in Shanghai and Medicare Health Products Co. in Hong Kong. Initial product shipments have been made to each of these distributors in support of anticipated first quarter 2005 launches. These partnerships are the beginning of Restore Medical’s growth plan to make the Pillar Procedure an option for the millions of people worldwide who suffer from OSA and snoring. In the coming year additional distributors will be added in Asia, Europe and South America. The Pillar Procedure has received strong acceptance in the United States since its clearance by the Food and Drug Administration in late 2004 as a first-line implantable treatment for mild-to-moderate obstructive sleep apnea (OSA), a serious health disorder that has been linked to heart disease, high blood pressure and stroke.